The long-term goal of this project remains the elucidation of the biological functions of glycosyl moieties on glycoconjugates important to development and immunity. During studies on lymphocytes, a new type of protein glycosylation (O-GlcNAc) was discovered. O-GlcNAc occurs in all eukaryotes from yeast to man on a myriad of nuclear and cytoplasmic proteins, including RNA polymerase II and its transcription factors, numerous chromatin-, nuclear pore-, cytoskeletal-, viral-, nuclear oncogene-, and heat shock-proteins. O-GlcNAc appears to be ubiquitous, abundant, and as dynamic as phosphorylation. Elucidation of O-GlcNAc's functions will be the focus of this project's next phase. Our plan is to: 1) Complete the characterization, clone the genes, and understand the regulation, of the enzymes that attach or remove O-GlcNAc. Complexity of gene families, regulation of the enzymes at the genomic, mRNA, and protein levels will be determined. Recombinant enzymes will be used to develop inhibitors, and to study the enzymes' structures. 2) Several approaches will evaluate the general significance of O-GlcNAc: A. CHO-mutant - Cytoplasmic constructs of Gal transferase cDNA will be transfected into gal-deficient CHO cells (LDL-d), and the deleterious effects of exogenous galactose on viability, growth, nuclear transport, transcription, and other properties will be evaluated. Preliminary data suggests that similar cytoplasmic constructs are lethal in wild-type cells. B. Yeast - O-GlcNAc transferase cDNA from yeast will be cloned. Classical gene knock-out experiments will be performed. Effects of glucosamine deprivation on O-GlcNAc will be studied in a yeast Ts auxotrophic for GlcN. C. Inhibitors - Inhibitors of O-GlcNAc transferase, such as polyoxins, and inhibitors of O-GlcNAcase, such as NAc-deoxynorjirimycin, will be studied. D. Anti-Sense - Overexpression of anti-sense cDNA for O-GlcNAc transferase and O-GlcNAcase will also be attempted to specifically effect O-GlcNAc metabolism. 3) Determine the relationship between O-GlcNAc and Ser/Thr phosphorylation: Initially, we will co-examine synthetic peptide substrates with pure O-GlcNAc transferase and purified kinases. Co-localization of sites on endogenous proteins and effects of phosphatase/kinase inhibitors on O-GlcNAc and vice versa will be determined. 4) Continue to Identify O-GlcNAc Attachment Sites for Site-Directed Mutagenesis: Initially, we will focus on RNA polymerase II, serum response and HNF-1 transcription factors, and Neurofilaments. 5) Dynamics of O-GlcNAc will be further explored in cellular activation, cell cycle, and developmental systems. Overall, these experiments will elucidate the functions of O-GlcNAc, a ubiquitous, abundant, and dynamic post-translational modification, which may have substantial impact on nearly all aspects of eukaryotic biology, including development and intracellular processes.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
7R01HD013563-20
Application #
2629070
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1979-12-01
Project End
1998-03-31
Budget Start
1997-10-01
Budget End
1998-03-31
Support Year
20
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Li, Xi; Molina, Henrik; Huang, Haiyan et al. (2009) O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation. J Biol Chem 284:19248-54
Housley, Michael P; Udeshi, Namrata D; Rodgers, Joseph T et al. (2009) A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem 284:5148-57
Cheung, Win D; Sakabe, Kaoru; Housley, Michael P et al. (2008) O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J Biol Chem 283:33935-41
Jones, Steven P; Zachara, Natasha E; Ngoh, Gladys A et al. (2008) Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117:1172-82
Cheung, Win D; Hart, Gerald W (2008) AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J Biol Chem 283:13009-20
Slawson, Chad; Lakshmanan, T; Knapp, Spencer et al. (2008) A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol Biol Cell 19:4130-40
Butkinaree, Chutikarn; Cheung, Win D; Park, Sungjin et al. (2008) Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis. J Biol Chem 283:23557-66
Housley, Michael P; Rodgers, Joseph T; Udeshi, Namrata D et al. (2008) O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem 283:16283-92
Dias, Wagner B; Hart, Gerald W (2007) O-GlcNAc modification in diabetes and Alzheimer's disease. Mol Biosyst 3:766-72
Tao, Guo-Zhong; Kirby, Celeste; Whelan, Stephen A et al. (2006) Reciprocal keratin 18 Ser48 O-GlcNAcylation and Ser52 phosphorylation using peptide analysis. Biochem Biophys Res Commun 351:708-12

Showing the most recent 10 out of 76 publications